InvestorsObserver
×
News Home

Will Amneal Pharmaceuticals Inc (AMRX) Stay at the Bottom of the Healthcare Sector?

Monday, September 26, 2022 03:50 PM | InvestorsObserver Analysts

Mentioned in this article

Will Amneal Pharmaceuticals Inc (AMRX) Stay at the Bottom of the Healthcare Sector?

Amneal Pharmaceuticals Inc (AMRX) is around the bottom of the Healthcare sector according to InvestorsObserver. AMRX received an overall rating of 31, which means that it scores higher than 31% of stocks. Additionally, Amneal Pharmaceuticals Inc scored a 20 in the Healthcare sector, ranking it higher than 20% of stocks in that sector.

Overall Score - 31
AMRX has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on AMRX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Amneal Pharmaceuticals Inc Stock Today?

Amneal Pharmaceuticals Inc (AMRX) stock is up 2.38% while the S&P 500 is down -0.76% as of 3:49 PM on Monday, Sep 26. AMRX has risen $0.05 from the previous closing price of $2.10 on volume of 747,897 shares. Over the past year the S&P 500 is down -17.51% while AMRX is down -59.66%. AMRX lost -$0.89 per share the over the last 12 months. Click Here to get the full Stock Report for Amneal Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App